Cataract Day
Continuing Medical Education
Target Audience
Anterior segment surgeons and comprehensive ophthalmologists who treat cataract patients
Educational Objectives
Ophthalmologists attending this program will be able to:
- Examine ASCRS Clinical Survey findings from 2019.
- Assess best practices in the diagnosis, preparation for, and surgical management of routine, challenging and complex cataract surgery cases.
- Discuss advanced cataract surgical considerations, to include refractive cataract surgery, patient communications and management, complicated cases and cutting-edge technologies.
- Identify pearls for using cataract surgical devices or technology and managing IOL complications or explanation.
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medial Education to provide continuing medical education for physicians. ASCRS takes responsibly for the content, quality and scientific integrity of the CME activity.
Designation Statement
The American Society of Cataract and Refractive Surgery designates this live activity for a maximum of 5 AMA PRA Category 1 Credits TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credits TM are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credits TM.
Claim CME/CE Credits
Attendees will be able to evaluate Cataract Day through the Claim CME/CE Credit Stations. The credit hours for Cataract Day are included in the overall ASCRS Annual Meeting credit hours for a total of 35 AMA PRA Category 1 Credits TM possible. When the evaluation is complete, attendees can print or email a copy of the certificate for continuing education credits for that day. If attendees do not complete the evaluations during the meeting, they will have the opportunity to complete them post meeting. Deadline is May 28, 2020.
Notice About Off-Label Use Presentations
The ASCRS Annual Meeting may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.
ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.
